Jerzy Stańczyk

Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment

Synovitis in osteoarthritis: current understanding with therapeutic implications

Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review

Synovial Tissue Inflammation Mediated by Autoimmune T Cells

Position Stand on Androgen and Human Growth Hormone Use

Neutrophil function in inflammation and inflammatory diseases

The Pathogenesis of Rheumatoid Arthritis

Inflammation and tumor progression: signaling pathways and targeted intervention

Evidence that cytokines play a role in rheumatoid arthritis

An update on the pathophysiology of osteoarthritis

Sex differences in immune responses

Sex Differences in Autoimmune Disease from a Pathological Perspective

Garden of therapeutic delights: new targets in rheumatic diseases

Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis

Energy security and sustainable competitiveness of industry development

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints

Psoriasis Pathogenesis and Treatment

Energy Efficiency in the Long-Run in the Selected European Countries

Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement

Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis

Myocardial Infarction in a 17-Year-Old Body Builder Using Clenbuterol

EUROPEAN SECURITY AND SUSTAINABILITY ISSUES IN THE CONTEXT OF CURRENT INTERNATIONAL ENVIRONMENT

Inhibited apoptosis of synovial fluid lymphocytes in children with juvenile idiopathic arthritis is associated with increased expression of myeloid cell leukemia 1 and XIAP proteins.